Publication | Open Access
Selection of Retapamulin, a Novel Pleuromutilin for Topical Use
91
Citations
5
References
2006
Year
Staphylococcus AureusPleural EffusionPharmacotherapyAntimicrobial ChemotherapyDrug ResistanceMedicinal ChemistryTopical DrugNovel PleuromutilinPleural DiseaseCommunity AntibioticsStreptococcus PyogenesInfection ControlAntimicrobial ResistanceHealth SciencesPharmacologyClinical MicrobiologyAntimicrobial SusceptibilityAntibioticsWound HealingMedicineDrug Discovery
The in vitro activity of retapamulin was determined and compared to that of topical and community antibiotics. The MIC(90)s of retapamulin against Staphylococcus aureus and Streptococcus pyogenes were 0.12 microg/ml and 0.016 microg/ml, respectively. Retapamulin has a low propensity to select resistance and produces an in vitro postantibiotic effect.
| Year | Citations | |
|---|---|---|
Page 1
Page 1